AnaptysBio, Inc. (ANAB)

AnaptysBio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	576	403	569	881	961	588
Market Cap Growth	-5.41%	-29.23%	-35.39%	-8.28%	63.38%	33.35%
Enterprise Value	582	340	486	760	608	251
Last Close Price	19.59	13.24	21.42	30.99	34.75	21.50
Forward PE	-	-	-	-	16.86	-
PS Ratio	5.14	4.41	33.18	85.65	15.21	7.84
PB Ratio	17.50	5.69	6.46	3.36	2.70	1.48
P/TBV Ratio	16.92	5.69	6.46	3.36	2.70	1.48
EV/Sales Ratio	5.20	3.72	28.31	73.84	9.62	3.34
Debt / Equity Ratio	10.17	5.21	3.73	1.24	0.76	0.00
Asset Turnover	0.27	0.20	0.03	0.02	0.12	0.18
Quick Ratio	8.13	9.38	10.62	16.99	34.10	19.86
Current Ratio	8.25	9.51	10.87	17.17	34.40	20.01
Return on Equity (ROE)	-343.83%	-182.71%	-93.44%	-41.62%	-15.35%	-4.97%
Return on Assets (ROA)	-15.14%	-15.35%	-18.47%	-11.48%	-6.70%	-3.50%
Return on Capital (ROIC)	-16.60%	-16.77%	-19.58%	-11.85%	-6.93%	-3.71%
Earnings Yield	-24.43%	-36.05%	-28.74%	-14.61%	-6.02%	-3.39%
FCF Yield	-18.96%	-33.68%	-21.36%	-8.39%	-4.92%	-2.50%
Buyback Yield / Dilution	-10.16%	-5.42%	4.41%	-2.68%	-0.47%	-0.90%

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q